Anxiety and Related Sleep Disorders - Americas

  • Americas
  • Revenue in the Anxiety and Related Sleep Disorders market is projected to reach US$4.07bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.49%, resulting in a market volume of US$4.17bn by 2029.
  • In global comparison, most revenue will be generated in the United States (US$3,213.00m in 2024).
  • In relation to total population figures, per person revenues of US$57.23 are generated in 2024.

Key regions: China, United States, Germany, India, Canada

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Anxiety and Related Sleep Disorders market in Americas is experiencing significant growth due to increasing customer preferences for alternative therapies and rising awareness about mental health issues.

Customer preferences:
Customers in the Americas are increasingly seeking alternative therapies for anxiety and related sleep disorders. They are gravitating towards natural and holistic approaches, such as herbal remedies, meditation, and yoga, rather than relying solely on pharmaceutical drugs. This shift in preferences is driven by a desire for more personalized and holistic treatment options that address the root causes of anxiety and sleep disorders.

Trends in the market:
One of the key trends in the Anxiety and Related Sleep Disorders market in the Americas is the growing popularity of cannabidiol (CBD) products. CBD, a non-psychoactive compound derived from the cannabis plant, is believed to have therapeutic effects on anxiety and sleep disorders. The legalization of medical and recreational cannabis in several states in the Americas has led to a surge in the production and consumption of CBD products. This trend is expected to continue as more research is conducted on the potential benefits of CBD for anxiety and sleep disorders.Another trend in the market is the increasing adoption of digital therapeutics for the treatment of anxiety and related sleep disorders. Digital therapeutics, such as smartphone apps and wearable devices, offer convenient and accessible solutions for managing these conditions. These technologies provide users with tools for relaxation, cognitive behavioral therapy, and sleep tracking, among other features. The convenience and affordability of digital therapeutics make them attractive options for individuals seeking self-help solutions for anxiety and sleep disorders.

Local special circumstances:
In the Americas, there are several local special circumstances that impact the Anxiety and Related Sleep Disorders market. For example, the United States has a large population of individuals suffering from anxiety and sleep disorders, which is driving the demand for innovative treatment options. Additionally, the high levels of stress associated with urban lifestyles in countries like Brazil and Mexico contribute to the prevalence of anxiety and sleep disorders in these regions. The cultural acceptance of alternative therapies and the availability of natural resources for herbal remedies also play a role in shaping customer preferences in the Americas.

Underlying macroeconomic factors:
The growing Anxiety and Related Sleep Disorders market in the Americas is influenced by several macroeconomic factors. Economic growth and rising disposable incomes in the region have increased the affordability of alternative therapies and digital therapeutics. The aging population in countries like the United States and Canada has also contributed to the demand for treatments for anxiety and sleep disorders, as these conditions are more common among older adults. Additionally, the increasing awareness and destigmatization of mental health issues in the Americas have led to a greater recognition of the need for effective treatments for anxiety and related sleep disorders.

Methodology

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Patients
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)